SVA — Sernova Biotherapeutics Share News
0.000.00%
Last trade - 00:00- CA$43.43m
- CA$57.97m
Brief: Sernova Receives Authorization To Enroll Second Patient Group For Type 1 Diabetes Trial
Brief: Sernova Announces The Appointment Of Daniel Mahony, Ph.D. To Its Board Of Directors
Brief: Sernova Says It Receives Second Tranche Equity Investment Of $6.8 Mln
Canada Research Roundup: Boralex, Dexterra Group, Sernova
Brief: Sernova Announces Positive Updated Phase 1/2 Clinical Data On Cell Pouch System
Brief: Sernova And Evotec Enter Into An Exclusive Global Strategic Partnership For IPSC-Based Beta Cell Replacement Therapy
Brief: Evotec And Sernova Announce Exclusive Strategic Partnership For IPSC-Based Beta Cell Replacement Therapy
Brief: Sernova Corp Announces C$10 Million Bought Deal Offering Of Units
Brief: Sernova Corp - David Swetlow Has Joined Sernova As Chief Financial Officer
Brief: Sernova Initiates Patient Screening And Recruitment For Its US Clinical Trial For Diabetes
Brief: Sernova Says Sean Hodgins Has Joined As CFO, Effective Immediately
Brief: Sernova Receives Us Fda Ind Allowance To Initiate A Us Clinical Trial Of Its Cell Pouch
Brief: Sernova to appoint Scott Langille as new CFO
Brief: Sernova and JDRF to fund joint research to advance human clinical trials for treatment of hypoglycemic unawareness patients
Brief: Sernova and JDRF announce funding of joint research collaboration
Brief: Sernova increases private placement to $4.2 mln
Brief: Sernova announces $2,000,000 first closing of private placement
Brief: Sernova announces non-brokered private placement
Brief: Sernova says arranged a non-brokered private placement for gross proceeds of $2,000,000